CD55 / DAF Mouse Monoclonal Antibody [Clone ID: 67]
CAT#: SM1141R
CD55 / DAF mouse monoclonal antibody, clone 67, PE
Need it in bulk or conjugated?
Get a free quote
CNY 6,369.00
货期*
4周
规格
Cited in 1 publication. |
Specifications
Product Data | |
Clone Name | 67 |
Applications | FC |
Recommend Dilution | Flow cytometry. |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | K562 cells |
Specificity | This antibody reacts to CD55, also known as DAF. |
Formulation | PBS, pH 7.4 containing 0.09% Sodium Azide as preservative and 1% BSA as stabilizer. Label: PE State: Lyophilized purified IgG fraction. Label: R. Phycoerythrin (RPE) |
Reconstitution Method | Restore with distilled water. |
Purification | Affinity chromatography on Protein G. |
Conjugation | PE |
Storage Condition | Prior to and following reconstitution store the antibody undiluted at 2-8°C. DO NOT FREEZE! This product is photosensitive and should be protected from light. |
Gene Name | CD55 molecule (Cromer blood group) |
Database Link | |
Background | CD55 is the complement regulatory protein, decay accelerating factor (DAF). It is a 70kD glycoprotein (in erythrocytes) anchored in the membrane by glycosylphosphatidylinositol tail. In other cells the apparent molecular weight is somewhat larger. It has a substantial content of O-glycans, and also on N-glycan. DAF binds to activated C4b or C3b complement fragments on the cell surface, preventing the assembly and accelerating the decay of both classical and alternative pathways. DAF carries the Cromer related blood group antigens. DAF has a wide distribution on cells in non-haemopoietic tissues, particularly epithelium and is specifically found at the foetal-maternal interface in placenta. Soluble forms of DAF are found, for example, in plasma, saliva and urine. The antigen on erythrocytes is pronase and chymotrypsin sensitive, but resistant to trypsin. |
Synonyms | CR; CROM; DAF; TC |
Reference Data |
Citations (1)
The use of this Antibodies has been cited in the following citations: |
---|
Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy
,Wenzel K, Zabojszcza J, Carl M, Taubert S, Lass A, Harris CL, Ho M, Schulz H, Hummel O, Hubner N, Osterziel KJ, Spuler S,
J. Immunol.
,PubMed ID 16237120
[CD55]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...